Junel

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 14, 2023
Approval ID: 8b82ad14-580c-4145-b825-dce849f95363
Products: 4 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Junel 21 Day (norethindrone acetate and ethinyl estradiol tablets USP)Junel Fe 28 Day(norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets*)*Ferrous fumarate tablets are not USP for dissolution and assay.

Quick Stats

Total Products4

Labelers2

Label Sections28

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.